PulsePress
Technology•Ars Technica•

FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

Originally published by Ars Technica
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Image provided by Ars Technica.

The risk appears small and data is mixed, but FDA wants patients to be aware.

Original reporting

Read the full story at the original publisher

PulsePress is a news discovery platform. We bring headlines from multiple publishers together so you can discover stories in one place. The complete reporting remains with the original publisher.

Read original article →